Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02115243
Title Trial of Neoadjuvant Ipilimumab Followed by Melphalan Via Isolated Limb Infusion for Patients With Unresectable In-transit Extremity Melanoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Duke University




Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Duke University Medical Center Durham North Carolina 27707 United States Details
*Shaded cells indicate that there was no data available from for the field